Skip to content

Climb Bio, Inc. CLYM Total Liabilities

Total Liabilities at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$66.37B-11.5%
Vera Therapeutics logo
Vera TherapeuticsVERA
$122.04M+62.4%
Kyverna Therapeutics, Inc. logo
Kyverna Therapeutics, Inc.KYTX
$61.44M+67.7%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$36.81M+32.2%
Jade Biosciences, Inc. Common Stock logo
Jade Biosciences, Inc. Common StockJBIO
$22.97M+824%
Amgen logo
AmgenAMGN

Other financials

Income statement

See full
Operating income-$15.2M+33.9%
Net income-$13.7M+34.0%
EPS (diluted)-$0.20+35.5%

Balance sheet

See full
Cash & equivalents$8.4M-71.2%
Total debt$479.0K+1.1%
Total equity$148.1M-23.4%
Total assets$152.4M-24.1%

Cash flow

See full
Operating cash flow-$14.4M+6.8%
CapEx$109.0K
Free cash flow-$15.6M-183%

Valuation

See full
Market cap$724.95M+787%
Enterprise value$717.07M+1,247%

Returns & leverage

See full
Return on equity-30.9%-10.3pp
Debt / equity0.0×
Current ratio27.9×+13.6×

Where this comes from

Reported directly by Climb Bio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The official record: Climb Bio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Climb Bio, Inc.'s total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Climb Bio, Inc.'s total liabilities?
Climb Bio, Inc. (CLYM) reported total liabilities of $4.29M in Q1 2026.
How has Climb Bio, Inc.'s total liabilities changed year-over-year?
Climb Bio, Inc.'s total liabilities decreased by 41.7% year-over-year, from $7.36M to $4.29M.
What is the long-term trend for Climb Bio, Inc.'s total liabilities?
Over 5 years (2020 to 2025), Climb Bio, Inc.'s total liabilities has grown at a 18.9% compound annual growth rate (CAGR), from $3.06M to $7.27M.
What does total liabilities mean?
The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.